In Brief: National uniformity legislation
This article was originally published in The Tan Sheet
Executive Summary
National uniformity legislation: Rep. Richard Burr's (R-N.C.) HR 1411, introduced April 23, includes national uniformity language that prohibits states from enacting any requirements inconsistent with the federal Public Health Service Act or the Fair Packaging & Labeling Act, including any "notification requirement for a drug package thereof." The "Drug & Biological Products Modernization Act," which remains virtually unchanged from a July discussion draft, updates Burr's HR 3199 introduced in the 104th Congress. Pushing for national uniformity in OTC drug regulation remains one of the Nonprescription Drug Manufacturers Association's top legislative priorities...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning